Emerging Therapies for the Management of Human Epidermal Growth Factor Receptor 2-/ERBB2-Altered Advanced Biliary Tract Cancers

被引：0

作者：

Zeme, Emily L. ^{[1
]}

Van Loon, Katherine ^{[1
,2
]}

Kelley, Robin K. ^{[1
,2
]}

Gordan, John D. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[2] UCSF, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 27期

关键词：

METASTATIC BREAST-CANCER; TRASTUZUMAB; PLACEBO; FOLFOX;

D O I：

10.1200/JCO.24.00868

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

引用

页数：8

共 50 条

[21] MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab plus Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors
Sweeney, Christopher J.
Hainsworth, John D.
Bose, Ron
Burris, Howard A.
Kurzrock, Razelle
Swanton, Charles
Friedman, Claire F.
Spigel, David R.
Szado, Tania
Schulze, Katja
Price, Richard
Malato, Julia
Lo, Amy A.
Levy, Jonathan
Wang, Yong
Yu, Wei
Meric-Bernstam, Funda
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (03) : 258 - 265
[22] Evaluation of Human Epidermal Growth Factor Receptor 2 Expression in Gastric and Gastroesophageal Cancers in Tanzania
Ngaiza, Advera
Vuhahula, Edda
Yahaya, James
Ndayisaba, Marie Claire
Kawishe, Gerald J.
Grenert, James P.
Zhang, Li
Van Loon, Katherine
Ng, Dianna L.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (12) : 1523 - 1529
[23] Management of hormone-receptor positive human epidermal receptor 2 negative advanced or metastatic breast cancers
Ngan, Roger K. C.
ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (14)
[24] Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies
Florido, Roberta
Smith, Karen L.
Cuomo, Kimberly K.
Russell, Stuart D.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
[25] Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia
Liu, ZG
Carvajal, M
Carraway, CAC
Carraway, K
Pflugfelder, SC
CORNEA, 2001, 20 (01) : 81 - 85
[26] Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma
Visco, V
Carico, E
Marchese, C
Torrisi, MR
Frati, L
Vecchione, A
Muraro, R
INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (03) : 431 - 435
[27] Overview on Current Trends and Emerging Therapies in the Chemotherapy of Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Qian, Jian
Xu, Yunxia
Ling, Xiaokai
Wang, Fenhua
GALEN MEDICAL JOURNAL, 2023, 12
[28] Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization
Hughes, Juliana Bentes
Berger, Christian
Rodland, Marianne Skeie
Hasmann, Max
Stang, Espen
Madshus, Inger Helene
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (07) : 1885 - 1892
[29] The human epidermal growth factor receptor 2 (HER2)
Tafe, Laura J.
Tsongalis, Gregory J.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (01) : 23 - 30
[30] Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 PET Imaging Challenges and Opportunities
Ducharme, Maxwell
Mansur, Ameer
Sligh, Luke
Ulaner, Gary A.
Lapi, Suzanne E.
Sorace, Anna G.
PET CLINICS, 2023, 18 (04) : 543 - 555

← 1 2 3 4 5 →